140 related articles for article (PubMed ID: 20466538)
1. Functional characterisation of cell cycle-related kinase (CCRK) in colorectal cancer carcinogenesis.
An X; Ng SS; Xie D; Zeng YX; Sze J; Wang J; Chen YC; Chow BK; Lu G; Poon WS; Kung HF; Wong BC; Lin MC
Eur J Cancer; 2010 Jun; 46(9):1752-61. PubMed ID: 20466538
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma.
Ng SS; Cheung YT; An XM; Chen YC; Li M; Li GH; Cheung W; Sze J; Lai L; Peng Y; Xia HH; Wong BC; Leung SY; Xie D; He ML; Kung HF; Lin MC
J Natl Cancer Inst; 2007 Jun; 99(12):936-48. PubMed ID: 17565152
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma.
Wu GQ; Xie D; Yang GF; Liao YJ; Mai SJ; Deng HX; Sze J; Guan XY; Zeng YX; Lin MC; Kung HF
Int J Cancer; 2009 Dec; 125(11):2631-42. PubMed ID: 19672860
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
Al-Aynati MM; Radulovich N; Ho J; Tsao MS
Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis.
Feng H; Cheng AS; Tsang DP; Li MS; Go MY; Cheung YS; Zhao GJ; Ng SS; Lin MC; Yu J; Lai PB; To KF; Sung JJ
J Clin Invest; 2011 Aug; 121(8):3159-75. PubMed ID: 21747169
[TBL] [Abstract][Full Text] [Related]
6. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
[TBL] [Abstract][Full Text] [Related]
7. The cyclin-dependent kinase (CDK) family member PNQALRE/CCRK supports cell proliferation but has no intrinsic CDK-activating kinase (CAK) activity.
Wohlbold L; Larochelle S; Liao JC; Livshits G; Singer J; Shokat KM; Fisher RP
Cell Cycle; 2006 Mar; 5(5):546-54. PubMed ID: 16552187
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis.
Yu Z; Gao YQ; Feng H; Lee YY; Li MS; Tian Y; Go MY; Yu DY; Cheung YS; Lai PB; Yu J; Wong VW; Sung JJ; Chan HL; Cheng AS
Gut; 2014 Nov; 63(11):1793-804. PubMed ID: 24440987
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle-related kinase in carcinogenesis.
Tian Y; Wan H; Tan G
Oncol Lett; 2012 Oct; 4(4):601-606. PubMed ID: 23205069
[TBL] [Abstract][Full Text] [Related]
10. A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients.
Feng H; Yu Z; Tian Y; Lee YY; Li MS; Go MY; Cheung YS; Lai PB; Chan AM; To KF; Chan HL; Sung JJ; Cheng AS
J Hepatol; 2015 May; 62(5):1100-11. PubMed ID: 25500144
[TBL] [Abstract][Full Text] [Related]
11. CCRK depletion inhibits glioblastoma cell proliferation in a cilium-dependent manner.
Yang Y; Roine N; Mäkelä TP
EMBO Rep; 2013 Aug; 14(8):741-7. PubMed ID: 23743448
[TBL] [Abstract][Full Text] [Related]
12. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.
Zhou J; Liu M; Sun H; Feng Y; Xu L; Chan AWH; Tong JH; Wong J; Chong CCN; Lai PBS; Wang HK; Tsang SW; Goodwin T; Liu R; Huang L; Chen Z; Sung JJ; Chow KL; To KF; Cheng AS
Gut; 2018 May; 67(5):931-944. PubMed ID: 28939663
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide.
Shi MD; Lin HH; Lee YC; Chao JK; Lin RA; Chen JH
Chem Biol Interact; 2008 Aug; 174(3):201-10. PubMed ID: 18619950
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.
Higashi H; Suzuki-Takahashi I; Saitoh S; Segawa K; Taya Y; Okuyama A; Nishimura S; Kitagawa M
Eur J Biochem; 1996 Apr; 237(2):460-7. PubMed ID: 8647086
[TBL] [Abstract][Full Text] [Related]
15. Activation of cyclin E-dependent kinase activity in colorectal cancer.
Cam WR; Masaki T; Shiratori TY; Kato N; Okamoto M; Yamaji Y; Igarashi K; Sano T; Omata M
Dig Dis Sci; 2001 Oct; 46(10):2187-98. PubMed ID: 11680595
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes.
Cheney IW; Neuteboom ST; Vaillancourt MT; Ramachandra M; Bookstein R
Cancer Res; 1999 May; 59(10):2318-23. PubMed ID: 10344736
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
[TBL] [Abstract][Full Text] [Related]
18. Critical role for p27Kip1 in cell cycle arrest after androgen depletion in mouse mammary carcinoma cells (SC-3).
Menjo M; Kaneko Y; Ogata E; Ikeda K; Nakanishi M
Oncogene; 1998 Nov; 17(20):2619-27. PubMed ID: 9840925
[TBL] [Abstract][Full Text] [Related]
19. Saucernetin-7 isolated from Saururus chinensis inhibits proliferation of human promyelocytic HL-60 leukemia cells via G0/G1 phase arrest and induction of differentiation.
Seo BR; Lee KW; Ha J; Park HJ; Choi JW; Lee KT
Carcinogenesis; 2004 Aug; 25(8):1387-94. PubMed ID: 15033903
[TBL] [Abstract][Full Text] [Related]
20. hcrcn81 promotes cell proliferation through Wnt signaling pathway in colorectal cancer.
Chen Y; Jiang T; Shi L; He K
Med Oncol; 2016 Jan; 33(1):3. PubMed ID: 26607374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
